The British Skin Foundation, a charity dedicated to raising funds for skin disease research, has conducted a survey amongst 245 dermatologists indicating that 87% believe that there is a lack of access to psychological support for those suffering with skin conditions in the UK.
AlmirallShare, a proprietary of Spanish pharmaceutical company Almirall, has launched to aim to find medical professionals to identify, validate or test new treatments for chronic immune-inflammatory diseases of the skin.
The European Investment Bank (EIB) has granted a €120 multimillion loan to Spanish pharmaceutical company Almirall under the investment plan for Europe.
According to a study published in Nature journal, researchers in Australia have discovered two rare forms of melanoma that are not caused by sun exposure unlike the cutaneous melanoma that is strongly linked to UV radiation.
Aesthetic practitioners from all over the UK gathered at the Royal Society of Medicine on 1 Wimpole Street for the launch of the Epionce Daily Shield Lotion SPF 50 and to hear a talk from Epionce founder Dr Carl Thornfeldt.
The British Skin Foundation (BSF) has released a new survey suggesting that more than half of people have suffered from or continue to suffer from a skin disease.
The British Skin Foundation (BSF) celebrated its 20th anniversary at the Skin Deep: 20 Years of Research conference on October 13 at the Royal College of Physicians, London.
The Food and Drug Administration (FDA) has approved the use of adalimumab (Humira) in adults with moderate to severe hidradenitis suppurativa (HS).
The British Association of Dermatologists (BAD) has launched an online psychological support service for people who suffer from various skin conditions.
Distribution company ABC Lasers have added the 308 Excimer System to its product portfolio. With a wavelength of 308nm, ABC says that the system is ideally suited to treat psoriasis, vitiligo and alopecia areata, amongst other aesthetic indications.